argenx Surges to 391st in Trading Volume with $244 Million in Shares Traded Despite Stock Price Decline

On March 24, 2025, argenx (ARGX) saw a significant increase in trading volume, with a total of $244 million in shares traded, marking a 58.33% rise from the previous day. This surge placed argenx at the 391st position in terms of trading volume for the day. However, despite the high trading volume, the stock price of argenx declined by 1.15%.

argenx's dividend history, as provided by Nasdaq, offers a clear view of the company's historical dividend payouts. This data can be instrumental in assessing the company's long-term performance and stability, which is crucial for investors analyzing individual stocks.

Simplify Asset Management Inc. recently reduced its stake in argenx, reflecting a strategic shift in its investment portfolio. This move comes as analysts predict that argenx will report earnings per share of $3.13 for the current year, indicating a positive outlook for the company's financial performance.

In the latest quarterly report, argenx reported earnings per share of $1.58, surpassing the consensus estimate of $0.98 by $0.60. This strong performance highlights the company's ability to exceed market expectations and demonstrates its robust financial health.

The biotech industry, which includes argenx, is showing signs of a potential bullish turnaround. This shift could bode well for argenx, as a favorable market environment could drive increased investor interest and stock performance.

Sei Investments Co. holds a substantial stake in argenx, valued at $225.48 million. This significant investment underscores the confidence that institutional investors have in argenx's growth prospects and long-term viability.

Victory Capital Management Inc. has also made adjustments to its stock position in argenx, reflecting ongoing strategic decisions by major investors. The stock's 52-week range, from a low of $352.77 to a high of $678.21, provides a context for its recent price movements and market volatility.

HighTower Advisors LLC recently acquired 3,961 shares of argenx, adding to the growing list of institutional investors showing interest in the company. This acquisition comes as argenx continues to demonstrate strong financial performance and market potential.